ONC Required Information

Similar documents
Meaningful Use Certification Details

MEANINGFUL USE STAGE 2

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 2

Computer Provider Order Entry (CPOE)

Ophthalmology Meaningful Use Attestation Guide 2016 Edition Updated July 2016

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 1

Falcon Quality Payment Program Checklist- 2017

during the EHR reporting period.

Meaningful Use Measures: Quick Reference Guide Stage 2 (2014 and Beyond)

REQUIREMENTS GUIDE: How to Qualify for EHR Stimulus Funds under ARRA

Qualifying for Medicare Incentive Payments with Crystal Practice Management. Version 1.0

Sevocity v Advancing Care Information User Reference Guide

Quality Data Model (QDM) Style Guide. QDM (version MAT) for Meaningful Use Stage 2

Meaningful Use Stages 1 & 2

Stage 2 Meaningful Use Objectives and Measures

GE Healthcare. Meaningful Use 2014 Prep: Core Part 1. Ramsey Antoun, Training Operations Coordinator December 12, 2013

MEANINGFUL USE 2015 PROPOSED 2015 MEANINGFUL USE FLEXIBILITY RULE

Meaningful Use: Review of Changes to Objectives and Measures in Final Rule

Measures Reporting for Eligible Hospitals

Iatric Systems Supports the Achievement of Meaningful Use

Stage 1 Meaningful Use Objectives and Measures

Meaningful Use Reporting period for 2017: Change: Any consecutive 90 days in 2017 for Medicaid customers only.

STAGE 2 PROPOSED REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1

The HITECH EHR "Meaningful Use" Requirements for Hospitals and Eligible Professionals

HIE Implications in Meaningful Use Stage 1 Requirements

PROPOSED MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Eligible Professionals (EP) Meaningful Use Final Objectives and Measures for Stage 1, 2011

Appendix 4 CMS Stage 1 Meaningful Use Requirements Summary Tables 4-1 APPENDIX 4 CMS STAGE 1 MEANINGFUL USE REQUIREMENTS SUMMARY

THE MEANING OF MEANINGFUL USE CHANGES IN THE STAGE 2 MU FINAL RULE. Angel L. Moore, MAEd, RHIA Eastern AHEC REC

APPENDIX 2 NCQA PCMH 2011 AND CMS STAGE 1 MEANINGFUL USE REQUIREMENTS

Measures Reporting for Eligible Providers

A complete step by step guide on how to achieve Meaningful Use Core Set Measures in Medgen EHR.

2015 MEANINGFUL USE STAGE 2 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Roll Out of the HIT Meaningful Use Standards and Certification Criteria

MEANINGFUL USE TRAINING SCENARIOS GUIDE

Medicaid EHR Incentive Program Health Information Exchange Objective Stage 3 Updated: February 2017

2018 Modified Stage 3 Meaningful Use Criteria for Eligible Professionals (EPs)*

Meaningful Use Stage 2

PCMH 2014 Recognition Checklist

Meaningful Use Stage 1 Guide for 2013

Clinical LOINC Meeting - Salt Lake City, UT USA. Updates on LOINC. Daniel J. Vreeman, PT, DPT, MSc

MEANINGFUL USE STAGE FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

CHCANYS NYS HCCN ecw Webinar

Table of Contents 2017 MIPS GUIDE 12/29/2017

Final Meaningful Use Objectives for 2017

PBSI-EHR Off the Charts Meaningful Use in 2016 The Patient Engagement Stage

Meaningful Use Participation Basics for the Small Provider

Meaningful Use Roadmap

ecw and NextGen MEETING MU REQUIREMENTS

Meaningful Use 2016 and beyond

INTERGY MEANINGFUL USE 2014 STAGE 2 USER GUIDE Spring 2014

Meaningful Use Modified Stage 2 Roadmap Eligible Hospitals

Meaningful Use - Modified Stage Alternate Exclusions and/or Specifications

Texas Medicaid Electronic Health Record (EHR) Incentive Program: Federally Qualified Health Centers (FQHCs)

in partnership with EHR Meaningful Use Guide for HITECH Attestation

Meaningful Use FAQs for Public Health

INTERGY MEANINGFUL USE 2014 STAGE 1 USER GUIDE Spring 2014

Medicare and Medicaid EHR Incentive Program. Stage 3 and Modifications to Meaningful Use in 2015 through 2017 Final Rule with Comment

Stage 2 Eligible Professional Meaningful Use Core and Menu Measures. User Manual/Guide for Attestation using encompass 3.0

CMS EHR Incentive Programs Overview

2017 Transition Into Value Based Care

Meaningful Use: Introduction to Meaningful Use Eligible Providers

Final Meaningful Use Objectives for

Meaningful Use May, 2012

Meaningful Use and PCC EHR. Tim Proctor Users Conference 2017

EHR Meaningful Use Guide

Russell B Leftwich, MD

of 23 Meaningful Use 2015 PER THE CMS REVISION TO THE FINAL RULE RELEASED OCTOBER 6, 2015 CHARTMAKER MEDICAL SUITE

Stage 2 Eligible Professional Meaningful Use Core Measures Measure 15 of 17 Last Updated: November 2013

Webinar #5 Meaningful Use: Looking Ahead to Stage 2 and CPS 12

Final Meaningful Use Objectives for

Meaningful Use and PCC EHR

Abstract. Are eligible providers participating? AdvancedMD EHR features streamline meaningful use processes: Complete & accurate information

Security Risk Analysis and 365 Days of Meaningful Use. Rodney Gauna & Val Tuerk, Object Health

EHR Incentive Programs for Eligible Professionals: What You Need to Know for 2016 Tipsheet

HITECH* Update Meaningful Use Regulations Eligible Professionals

Transforming Health Care with Health IT

Stage 2 Eligible Hospital and Critical Access Hospital Meaningful Use Core Measures Measure 12 of 16 Date issued: May 2013

CHIME Concordance Analysis of Stage 2 Meaningful Use Final Rule - Objectives & Measures

Meaningful Use Stage 2 For Eligible and Critical Access Hospitals

Meaningful Use Basics and Attestation Process Guide for Medicare and Medi-Cal. Lori Hack & Val Tuerk, Object Health

Harnessing the Power of MHS Information Systems to Achieve Meaningful Use of Health Information

MEANINGFUL USE BASICS

HITECH Act American Recovery and Reinvestment Act (ARRA) Stimulus Package. HITECH Act Meaningful Use (MU)

Medicare & Medicaid EHR Incentive Programs. Stage 2 Final Rule Travis Broome AMIA

Go! Knowledge Activity: Meaningful Use and the Hospital EHR

Care Management Policies

Possible Denominator Codes Applicable to OMS * Le Fort Fractures 21346, 21347, 21348, 21422, 21423, 21432, 21433, 21435, 21436

American Recovery & Reinvestment Act

Understanding Your Meaningful Use Report

ASCs and Meaningful Use. Patrick Doyle, Vice President Sales Jessica McBrayer, RN, Business Analyst Ron Pelletier, Vice President Market Strategy

PCSP 2016 PCMH 2014 Crosswalk

EHR/Meaningful Use

Agenda 2. EHR Incentive Programs 3/5/2015. Overview EHR incentive programs Meaningful Use Differences between Stage 1 and Stage 2

The History of Meaningful Use

2011 Measures 2013 Objectives Goal is to guide and support care processes and care coordination

Advancing Care Information Measures Data Validation Criteria. Reporting Requirement: Yes/No or Numerator/Denominator

The results will also be used for public reporting for MN Community Measurement on mnhealthscores.org.

HIE Implications in Meaningful Use Stage 1 Requirements

Eligibility. Program Structure and Process for Receiving Incentives

Transcription:

ONC Required Information Costs and Limitations Disclosures for Meaningful Use February 19, 2019 Cerberus Healthcare, LLC 816 S. Main Street Summerville, SC 29483 (888)825-4258 www.clicktate.com

2 P a g e

Table of Contents Disclaimers 4 Certification Information 5 Criteria Certified 6 Clinical Quality Measures Certified 9 Additional Costs 11 Contractual Limitations 12 Technical Limitations 13 Certificate of Certification from SLI Compliance 14 3 P a g e

Disclaimers This Complete Electronic Health Record (EHR) is 2014 Edition Compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services. ONC CERTIFIED HIT is a registered trademark of HHS. SLI CERTIFIED is a registered trademark of Gaming Laboratories International, LLC dba SLI Compliance. 4 P a g e

Certification Information Developer Name: Product Name: Version: Certifying Body: Certification Number: Cerberus Healthcare, LLC Clicktate 5.0 (Ambulatory) SLI Compliance 14.05.05.1777.CLIC.01.00.1.190222 Certification Date: February 22, 2019 Relied Upon Software: Microsoft Excel (170.314(a)(14)- Patient list creation 170.314(a)(8) Clinical decision support 170.314(d)(3) Audit report(s) 170.314(g)(1)(g)(2) Automated numerator recording and Measure Calculation- Patient Lists, Sorting NewCrop RX (included in system)- Electronic Rx, Direct Messaging, Drug and Allergy Reconciliation Certification Information may be found at the ONC Certified Health IT Product List. 5 P a g e

Criteria Certified 170.314 (a)(1): Computerized provider order entry 170.314 (a)(2): Drug-drug, drug-allergy interactions checks 170.314 (a)(3): Demographics 170.314 (a)(4): Vital signs, body mass index, and growth Charts 170.314 (a)(5): Problem list 170.314 (a)(6): Medication list 170.314 (a)(7): Medication allergy list 170.314 (a)(8): Clinical decision support 170.314 (a)(9): Electronic notes 170.314 (a)(10): Drug formulary checks 170.314 (a)(11): Smoking status 170.314 (a)(12): Image results 170.314 (a)(13): Family health history 6 P a g e

170.314 (a)(14): Patient list creation 170.314 (a)(15): Patient-specific education resources 170.314 (b)(1): Transitions of care - receive, display and incorporate transition of care/referral summaries 170.314 (b)(2): Transitions of care - create and transmit transition of care/referral summaries 170.314 (b)(3): Electronic prescribing 170.314 (b)(4): Clinical information reconciliation 170.314 (b)(5)(a): Incorporate laboratory tests and values/results 170.314 (b)(7): Data portability 170.314 (c)(1): Clinical quality measures - capture and export 170.314 (c)(2): Clinical quality measures - import and calculate 170.314 (c)(3): Clinical quality measures - electronic submission 170.314 (d)(1): Authentication, access, control, and authorization 170.314 (d)(2): Auditable events and tamper-resistance 170.314 (d)(3): Audit report(s) 170.314 (d)(4): Amendments 170.314 (d)(5): Automatic log-off 7 P a g e

170.314 (d)(6): Emergency access 170.314 (d)(7): End-user device encryption 170.314 (d)(8): Integrity 170.314 (e)(1): View, download, and transmit to a 3rd party with edge protocol testing 170.314 (e)(2): Ambulatory setting only -clinical summary 170.314 (e)(3): Ambulatory setting only - secure messaging 170.314 (f)(1): Immunization information 170.314 (f)(2): Transmission to immunization registries 170.314 (f)(3): Transmission to public health agencies - syndromic surveillance 170.314 (g)(1): Automated numerator recording 170.314 (g)(2): Automated measure calculation 170.314 (g)(3): Safety-enhanced design 170.314 (g)(4): Quality management system 8 P a g e

Clinical Quality Measures (CQMs) Certified CMS2: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan Percentage of patients aged 12 years and older screened for clinical depression on the date of the encounter using an age appropriate standardized depression screening tool AND if positive, a follow-up plan is documented on the date of the positive screen. CMS50: Closing the Referral Loop: Receipt of Specialist Report Percentage of patients with referrals, regardless of age, for which the referring provider receives a report from the provider to whom the patient was referred. CMS68: Documentation of Current Medications in the Medical Record Percentage of visits for patients aged 18 years and older for which the eligible professional attests to documenting a list of current medications using all immediate resources available on the date of the encounter. This list must include ALL known prescriptions, overthe-counters, herbals, and vitamin/mineral/dietary (nutritional) supplements AND must contain the medications name, dosage, frequency and route of administration. CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan Percentage of patients aged 18 years and older with a BMI documented during the current encounter or during the previous six months AND with a BMI outside of normal parameters, a follow-up plan is documented during the encounter or during the previous 6 months of the current encounter. Normal parameters: Age 65 years and older BMI=>23 and <30 kg/m2. Age 18-64 years BMI=>18.5 and <25 kg/m2. 9 P a g e

CMS90: Functional Status Assessment for Complex Chronic Conditions Percentage of patients aged 65 years and older with heart failure who completed initial and follow-up patient reported functional status assessments. CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco user. CMS156: Use of High-Risk Medications in the Elderly Percentage of patients 66 years of age and older who were ordered high-risk medications. Two rates are reported. Percentage of patients who were ordered at least one high-risk medication. Percentage of patients who were ordered at least two different high-risk medications. CMS165: Controlling High Blood Pressure Percentage of patients 18-65 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90 mmhg) during the measurement period. CMS166: Use of Imaging Studies for Low Back Pain Percentage of patients 18-50 years of age with a diagnosis of low back pain who did not have an imaging study (plain X-ray, MRI, CT scan) within 28 days of the diagnosis. 10 P a g e

Additional Costs There is a one-time activation fee of $99 per provider. Service is licensed on a monthly per subscriber basis. Costs are found on the pricing page on the website. Support accounts are available at a reduced price. Price depends on the number of support users. We provide free on-line support and training during and after implementation. We offer on-site visits during implementation and for training during and after implementation. Rates depend on length of stay, distance travelled, and hotel and airline costs in effect at the time of travel. Laboratory interface development: $1500 per unidirectional (results-only) interface and $2500 per bidirectional (ordering and results) interface. Radiology interface development: $1500 per unidirectional (results-only) interface and $2500 per bidirectional (ordering and results) interface. Quality measure and discreet data element recording involves mapping of data to standard terminology groups such as ICD-9, ICD-10, CVX, SNOMED, CPT, and LOINC. There data sets may have their own licensing fees for which the client may be responsible. Client is responsible for costs of internet connections, internet connection equipment such as modems and routers, computers, tablets, smartphones and other equipment. We are happy to make recommendations on band-width, data-speeds, etc. Client is responsible for assuring adequate firewalls and virus protection is incorporated in their facilities. 11 P a g e

Contractual Limitations Client agrees to utilize the system in the manner in which it was designed. Client agrees to utilize the system in an ambulatory setting. Patients utilizing the Patient Portal must accept the terms and conditions of the Patient Portal at initial log-in. The Clicktate Privacy Policy is found on the web-site. The Clicktate Terms of Service are found on the web-site. 12 P a g e

Technical Limitations Speed of connection if based on client internet connection speed. We are happy to make recommendations based on anticipated usage. Clinical Quality Measures (CQMs) are updated annually by CMS and are implemented as soon as possible. Report generation depends on several factors including connection speeds, time constraints for data set, constraints for number of patients. For instance, a report involving 20,000 patients over 2 years will take considerably longer to generate than a report involving 50 patients over 1 week. 13 P a g e

14 P a g e

15 P a g e